Phase 1 study of RG7155, a novel anti-CSF1R antibody, in patients with locally advanced pigmented villonodular synovitis (PVNS).
2014 ◽
Vol 32
(15_suppl)
◽
pp. 10504-10504
◽
2018 ◽
Vol 19
(5)
◽
pp. 639-648
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 10561-10561
2010 ◽
Vol 28
(15_suppl)
◽
pp. 10012-10012
◽
2019 ◽
Vol 29
(2)
◽
pp. 101-104
2002 ◽
Vol 11
(2)
◽
pp. 188-190
◽
2019 ◽
Vol 8
(6)
◽
pp. e641-e646
◽